ZA92389B - Method for detection of anti-rna-antibodies - Google Patents

Method for detection of anti-rna-antibodies

Info

Publication number
ZA92389B
ZA92389B ZA92389A ZA92389A ZA92389B ZA 92389 B ZA92389 B ZA 92389B ZA 92389 A ZA92389 A ZA 92389A ZA 92389 A ZA92389 A ZA 92389A ZA 92389 B ZA92389 B ZA 92389B
Authority
ZA
South Africa
Prior art keywords
pct
rna
date sep
sec
antibodies
Prior art date
Application number
ZA92389A
Other languages
English (en)
Inventor
Walther Jacobus Van Venrooij
Jacobus Van Venrooij Walther
Rene Michael Antonius Hoet
Michael Antonius Hoet Rene
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA92389B publication Critical patent/ZA92389B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA92389A 1991-01-22 1992-01-20 Method for detection of anti-rna-antibodies ZA92389B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200121 1991-01-22

Publications (1)

Publication Number Publication Date
ZA92389B true ZA92389B (en) 1992-09-30

Family

ID=8207502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92389A ZA92389B (en) 1991-01-22 1992-01-20 Method for detection of anti-rna-antibodies

Country Status (15)

Country Link
US (1) US5385824A (fr)
EP (1) EP0568554B1 (fr)
JP (1) JP3288041B2 (fr)
KR (1) KR100244799B1 (fr)
AT (1) ATE126599T1 (fr)
AU (1) AU658860B2 (fr)
CA (1) CA2101166C (fr)
DE (1) DE69204157T2 (fr)
DK (1) DK0568554T3 (fr)
ES (1) ES2078733T3 (fr)
FI (1) FI107359B (fr)
GR (1) GR3017975T3 (fr)
IE (1) IE66750B1 (fr)
WO (1) WO1992013276A1 (fr)
ZA (1) ZA92389B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576186A (en) * 1994-09-01 1996-11-19 The University Of Kansas Diagnosis and monitoring of rheumatological diseases by detection of anti-EF1-α antibodies
ZA200303132B (en) * 2000-10-20 2004-09-23 Expression Diagnostics Inc Leukocyte expression profiling.
US7026121B1 (en) * 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20060263813A1 (en) * 2005-05-11 2006-11-23 Expression Diagnostics, Inc. Methods of monitoring functional status of transplants using gene panels
US20070248978A1 (en) * 2006-04-07 2007-10-25 Expression Diagnostics, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
US7645575B2 (en) * 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
WO2008021431A2 (fr) * 2006-08-14 2008-02-21 Xdx, Inc. Méthodes et compositions permettant de diagnostiquer et de surveiller l'état de rejet de greffe et de troubles immunitaires
US8148067B2 (en) * 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2012068107A2 (fr) * 2010-11-17 2012-05-24 University Of Florida Research Foundation, Inc. Autoanticorps dirigé contre le complexe arn-protéine détecté par pcr quantitative
EP3134732A2 (fr) * 2014-04-24 2017-03-01 Alnylam Pharmaceuticals, Inc. Méthodes et compositions de détection d'anticorps anti-médicament

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784942A (en) * 1984-11-05 1988-11-15 The Board Of Regents For The University Of Oklahoma Monoclonal antibodies against autoimmune RNA proteins
CA2050340A1 (fr) * 1989-02-27 1990-08-28 Corgenix, Inc. Methode et trousse diagnostique pour le depistage d'anticorps autoimmuns

Also Published As

Publication number Publication date
FI933291A0 (fi) 1993-07-21
AU658860B2 (en) 1995-05-04
US5385824A (en) 1995-01-31
CA2101166A1 (fr) 1992-07-23
CA2101166C (fr) 2003-05-20
EP0568554A1 (fr) 1993-11-10
AU1161592A (en) 1992-08-27
ES2078733T3 (es) 1995-12-16
EP0568554B1 (fr) 1995-08-16
DK0568554T3 (da) 1995-12-04
IE66750B1 (en) 1996-02-07
IE920132A1 (en) 1992-07-29
KR100244799B1 (ko) 2000-03-02
JPH06504620A (ja) 1994-05-26
FI933291A (fi) 1993-08-18
JP3288041B2 (ja) 2002-06-04
KR930703612A (ko) 1993-11-30
GR3017975T3 (en) 1996-02-29
DE69204157D1 (de) 1995-09-21
WO1992013276A1 (fr) 1992-08-06
ATE126599T1 (de) 1995-09-15
DE69204157T2 (de) 1996-03-21
FI107359B (fi) 2001-07-13

Similar Documents

Publication Publication Date Title
GR3017975T3 (en) Method for detection of anti-rna-antibodies.
EP1099102A4 (fr) Utilisation d'une olfactometrie artificielle pour detecter le niveau de presence de substances a analyser
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
ATE178357T1 (de) Nachweismethoden für c-raf-1-genes.5
DK0589943T3 (da) Mycobacterium-proteiner og anvendelse heraf
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
ES2093277T3 (es) Metodo para la deteccion de daño epitelial gastrico.
EP0693183A4 (fr) Methodes de determination de la susceptibilite au diabete chez des patients asymptomatiques
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
AU5336796A (en) Method for detecting allergy
IL122426A0 (en) Method of identifying persons susceptible to neuropsychiatric disorders
ATE130099T1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.
DE3572033D1 (en) Method for diagnosis of a.i.d.s.
RU94014977A (ru) Способ оценки уровня серонина в цельной крови
UA34212A (uk) Спосіб оцінки результатів лікування хворих на ранні форми сифілісу
UA9626A (uk) Спосіб діагностики вперше виявленого туберкульозу легень
UA31276A (uk) Спосіб діагностики хламідіозу і мікоплазмозу у хворих на ранній сифіліс